 Insider Purchases of the Week: Which Top Managers Are Voting with Their Money While the market is guessing where the S&P will go, insiders of large companies have clearly shown the direction. I've compiled the top five largest purchases from April 29-30. 1. **Churchill Capital Corp XII (CXIIU)** — $3.5 million Michael Stewart Klein, owner of 10% of shares, bought 350,000 securities at $10. When an insider with such a stake buys more, it's not speculation but confidence in the deal. A SPAC story, awaiting merger announcement. 2. **Iperionx Ltd (IPX)** — $2.08 million Chairman of the Board Hannigan Todd acquired 480,000 shares. Iperionx is a titanium producer, a key material for defense and aerospace. Titanium demand is rising amid global tensions. 3. **Zenas Biopharma (ZBIO)** — $1.07 million CEO Mouder Leon bought 60,000 shares at $17.79. Biopharma is always a bet on a specific drug. When a CEO increases their stake by +3%, it's worth studying the pipeline. 4. **Charter Communications (CHTR)** — $995 thousand Director Davis Wade increased his stake by 479% — the first purchase in a long time. The largest cable TV and internet operator in the US. A director's signal is one of the strongest. 5. **Pimco Dynamic Income Strategy Fund (PDX)** — $592 thousand Daniel Ivascyn, the head of Pimco, bought 28,779 shares of his own fund. When the manager of the world's largest bond fund invests personal money, it speaks volumes. **Conclusion:** Insiders are concentrating on three areas — SPAC deals (CXIIU), industrial titanium (IPX), and telecom (CHTR). Biotech and fixed income are targeted bets. Data: OpenInsider, April 29-30, 2026. AI analytics by ASI Biont.